Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up1.00% Nasdaq Up1.29%

Momenta Pharmaceuticals Inc. (MNTA)

-NasdaqGS
11.56 Up 0.01(0.09%) 4:00PM EDT
|After Hours : 11.56 0.00 (0.00%) 4:48PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 12,749   10,752   4,361   7,603  
Cost of Revenue -   -   -   -  
Gross Profit 12,749   10,752   4,361   7,603  
Operating Expenses
Research Development32,228  27,445  21,994  22,332  
Selling General and Administrative10,855  8,969  11,517  9,716  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (30,334) (25,662) (29,150) (24,445)
Income from Continuing Operations
Total Other Income/Expenses Net273  280  301  329  
Earnings Before Interest And Taxes(30,061)(25,382)(28,849)(24,116)
Interest Expense -   -   -   -  
Income Before Tax(30,061)(25,382)(28,849)(24,116)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(30,061)(25,382)(28,849)(24,116)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (30,061) (25,382) (28,849) (24,116)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (30,061) (25,382) (28,849) (24,116)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.